Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Kidney Neoplasms × pazopanib × Clear all

Phase

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 5 Relapsed Pediatric Solid Tumor 2 Ovarian Neoplasms 2 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Breast Neoplasms 1

Interventions

aldesleukin 8 Sunitinib 5 Interferon-alpha 4 Chemotherapy, Adjuvant 4 Blood Specimen Collection 4 pembrolizumab 3 Vincristine 3 Neoadjuvant Therapy 3 Dactinomycin 3 Cyclophosphamide 3 Bevacizumab 3 sargramostim 2 fludarabine phosphate 2 Robotic Surgical Procedures 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Gene Expression Profiling 2 Fluorouracil 2 Etoposide 2 Doxorubicin 2 Carboplatin 2 Amplified Fragment Length Polymorphism Analysis 2 tremelimumab 1 toripalimab 1 temsirolimus 1 spartalizumab 1 pazopanib 1 orantinib 1 motexafin gadolinium 1 keyhole-limpet hemocyanin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03571438 2020-01-18

COMBOREIN

University Hospital, Grenoble

Phase NA Unknown

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡